NYSEMKT: TOVX
Theriva Biologics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TOVX

Based on 1 analyst offering 12 month price targets for Theriva Biologics Inc

Min Forecast
$6.00+358.02%
Avg Forecast
$6.00+358.02%
Max Forecast
$6.00+358.02%

Should I buy or sell TOVX stock?

Based on 1 analyst offering ratings for Theriva Biologics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TOVX stock forecasts and price targets.

TOVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-13

1 of 1

TOVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TOVX$1.31$6.00+358.02%Strong Buy
CDT$0.55N/AN/A
INM$2.96N/AN/A
XBIO$2.44N/AN/A
TCRT$2.35N/AN/A

Theriva Biologics Stock Forecast FAQ

Is Theriva Biologics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: TOVX) stock is to Strong Buy TOVX stock.

Out of 1 analyst, 1 (100%) are recommending TOVX as a Strong Buy, 0 (0%) are recommending TOVX as a Buy, 0 (0%) are recommending TOVX as a Hold, 0 (0%) are recommending TOVX as a Sell, and 0 (0%) are recommending TOVX as a Strong Sell.

If you're new to stock investing, here's how to buy Theriva Biologics stock.

What is TOVX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TOVX price target, the average TOVX price target is $6.00, with the highest TOVX stock price forecast at $6.00 and the lowest TOVX stock price forecast at $6.00.

The Wall Street analyst predicted that Theriva Biologics's share price could reach $6.00 by Nov 13, 2025. The average Theriva Biologics stock price prediction forecasts a potential upside of 358.02% from the current TOVX share price of $1.31.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.